发育中脑惊厥性损伤及其与NMDA受体的关系

批准号:
39900160
项目类别:
青年科学基金项目
资助金额:
11.0 万元
负责人:
姜玉武
依托单位:
学科分类:
H0913.神经电活动异常与发作性疾病
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
张国军、熊晖、赵士刚、罗强、吴希如
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
在神经病理、电生理及分子水平,不同惊厥模型观察发育期大鼠惊厥后不同时间大脑皮层及海马神经元数目、突触重构、脑片放电、NMDA受体各亚基基因表达及功能的改变,并用反义技术从反面加以印证;同时观察发育期惊厥对远期惊厥易感性及学习记忆的影响,分析这些影响与上述改变的关系。以期认识发育中脑惊厥性损伤特点,为早期干预提供理论依据。
英文摘要
We used the in vivo and in vitro models to study the seizure-induced brain injury. We found that brief Mg2+-free treatment could make a cultured developing cortical neuron "seizure" model, this recurrent epileptiform discharge could induce transient mitochondrial dysfunction without obvious cell loss; in this model, relatively more immature neurons had less severe injury, but their injury occurred earlier. Although we had not found the obvious long term neuropathologic changes in the brain of rats after the seizures in early childhood, the susceptibility to seizure-induced brain injury, such as apoptosis, mossy fiber sprouting, and learning and memory defect after the second seizure in adulthood, increased in rats that had seizure experience during development, either febrile convulsion or the kainate convulsion. NMDA receptor (NR) expression up-regulated, NR function enhanced, and the intracellular calcium concentration ([Ca2+]i) increase played a role in this functional neuronal injury. NR antagonist, calcium channel blocker and IL-1 receptor antagonist can protect the neurons to some different extent from the [Ca2+]i increase and the mitochondrial functional change (MTT conversion rates decrease) after the recurrent epileptiform induced by transient Mg2+-free culture. These results had great significance to clarify the mechanism and long-term prognosis of the seizure-induced developmental brain injury, and to find the new therapeutic strategy for this injury.
专著列表
科研奖励列表
会议论文列表
专利列表
儿童罕见遗传性癫痫的新发病机制及新治疗策略研究
- 批准号:U22A20339
- 项目类别:联合基金项目
- 资助金额:255.00万元
- 批准年份:2022
- 负责人:姜玉武
- 依托单位:
NMDA受体基因突变在儿童癫痫中的致病机制
- 批准号:81971211
- 项目类别:面上项目
- 资助金额:59.0万元
- 批准年份:2019
- 负责人:姜玉武
- 依托单位:
NIPA2基因突变以及染色体15q11.2微缺失在儿童失神癫痫中的致病机制研究
- 批准号:81271439
- 项目类别:面上项目
- 资助金额:75.0万元
- 批准年份:2012
- 负责人:姜玉武
- 依托单位:
白质消融性白质脑病致病基因EIF2B5的突变功能研究
- 批准号:30772355
- 项目类别:面上项目
- 资助金额:29.0万元
- 批准年份:2007
- 负责人:姜玉武
- 依托单位:
发育期脑损伤后存活神经细胞的远期功能及基因表达研究
- 批准号:30270448
- 项目类别:面上项目
- 资助金额:20.0万元
- 批准年份:2002
- 负责人:姜玉武
- 依托单位:
国内基金
海外基金
